Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT107 in Sepsis Patients with Lymphopenia (IRIS-7B)
NCT02640807Phase 2Completed
- Sponsor
- RevImmune
- Start
- Jan 2016
- Primary completion
- Aug 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human interleukin-7 in sepsis, septic shock, sponsored by RevImmune. Started Jan 2016; status: completed.
02
Drugs
recombinant human interleukin-7
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT02640807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640807.